PEG-DAPD peptide

DAPD PEGlylated with 43 kDa branched PEG (polyethylene glycol); has the potential to be developed as a dual-acting peptide to treat type 2 diabetes, with prolonged in vivo activity, and without the GI side-effects

Also Known As:

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results